I have a serious question. I am not picking on you here I am just lazy and dont want to name

the list of those who also belong to the CTIX published author group. How the hell does Harris get this tidbit for his article and others didnt (or I failed to pay attn when they did)

"The company said that one of the stage 4 cancer patients, an 80-year-old woman with endometrium stroma sarcoma (a rare form of uterine cancer), has completed seven months worth of dosing already, a fact that bodes extremely well for Kevetrin"

Every thing I read before Harris mentioned "ONE patient". Nothing about sex or diagnosis. According to my general understanding something like that would border on violating HIPPA. This particular remark may have been a significant factor in the SP boost he produced